Operating Income (Loss) of enGene Holdings Inc. from 31 Oct 2022 to 31 Jan 2026

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
enGene Holdings Inc. quarterly and annual Operating Income (Loss) in USD history and change rate from 31 Oct 2022 to 31 Jan 2026.
  • enGene Holdings Inc. Operating Income (Loss) for the quarter ending 31 Jan 2026 was $31,185,000, a 17% decline year-over-year.
  • enGene Holdings Inc. Operating Income (Loss) for the twelve months ending 31 Jan 2026 was $127,737,000, a 63% decline year-over-year.
  • enGene Holdings Inc. annual Operating Income (Loss) for 2025 was $123,165,000, a 98% decline from 2024.
  • enGene Holdings Inc. annual Operating Income (Loss) for 2024 was $62,297,000, a 139% decline from 2023.
  • enGene Holdings Inc. annual Operating Income (Loss) for 2023 was $26,060,000, a 34% decline from 2022.
Source SEC data
View on sec.gov
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)

enGene Holdings Inc. Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $127,737,000 $31,185,000 -$4,572,000 -17% 01 Nov 2025 31 Jan 2026 10-Q 09 Mar 2026 2026 Q1
Q3 2025 $123,165,000 $39,481,000 -$22,026,000 -126% 01 Aug 2025 31 Oct 2025 10-K 22 Dec 2025 2025 FY
Q2 2025 $101,139,000 $29,947,000 -$13,188,000 -79% 01 May 2025 31 Jul 2025 10-Q 11 Sep 2025 2025 Q3
Q1 2025 $87,951,000 $27,124,000 -$9,814,000 -57% 01 Feb 2025 30 Apr 2025 10-Q 12 Jun 2025 2025 Q2
Q4 2024 $78,137,000 $26,613,000 -$15,840,000 -147% 01 Nov 2024 31 Jan 2025 10-Q 09 Mar 2026 2026 Q1
Q3 2024 $62,297,000 $17,455,000 -$7,013,000 -67% 01 Aug 2024 31 Oct 2024 10-K 22 Dec 2025 2025 FY
Q2 2024 $55,284,000 $16,759,000 -$10,511,000 -168% 01 May 2024 31 Jul 2024 10-Q 11 Sep 2025 2025 Q3
Q1 2024 $44,773,000 $17,310,000 -$12,573,000 -265% 01 Feb 2024 30 Apr 2024 10-Q 12 Jun 2025 2025 Q2
Q4 2023 $32,200,000 $10,773,000 -$6,140,000 -133% 01 Nov 2023 31 Jan 2024 10-Q 10 Mar 2025 2025 Q1
Q3 2023 $26,060,000 $10,442,000 01 Aug 2023 31 Oct 2023 10-K 19 Dec 2024 2024 FY
Q2 2023 $6,248,000 01 May 2023 31 Jul 2023 10-Q 10 Sep 2024 2024 Q3
Q1 2023 $4,737,000 01 Feb 2023 30 Apr 2023 10-Q 14 Jun 2024 2024 Q2
Q4 2022 $4,633,000 01 Nov 2022 31 Jan 2023 10-Q 11 Mar 2024 2024 Q1

enGene Holdings Inc. Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $123,165,000 -$60,868,000 -98% 01 Nov 2024 31 Oct 2025 10-K 22 Dec 2025 2025 FY
2024 $62,297,000 -$36,237,000 -139% 01 Nov 2023 31 Oct 2024 10-K 22 Dec 2025 2025 FY
2023 $26,060,000 -$6,633,000 -34% 01 Nov 2022 31 Oct 2023 10-K 19 Dec 2024 2024 FY
2022 $19,427,000 01 Nov 2021 31 Oct 2022 10-K 29 Jan 2024 2023 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.